Back to Companies
ZyVersa Therapeutics, Inc.
ZVSAOTCCIK: 0001859007
Recent Form 4 activity at ZyVersa Therapeutics, Inc. (ZVSA) spans 8 filings across 8 insiders (no open-market buying or selling). Glover Stephen C. (Chief Executive Officer, Director) is the most active by dollar volume, and the single largest transaction was $80.8K by Glover Stephen C.. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$199.6K
Purchases
$0
Sales
$0
Unique Insiders
8
Recent Insider Trades
8 loaded
| Jul 15 | ZVSA ZyVersa Therapeutics, Inc. | Park Min-Chul | Director | Award | $6.5K |
| Jul 15 | ZVSA ZyVersa Therapeutics, Inc. | Finizio Robert G | Director | Award | $6.5K |
| Jul 15 | ZVSA ZyVersa Therapeutics, Inc. | SAPIRSTEIN JAMES | Director | Award | $6.5K |
| Jul 15 | ZVSA ZyVersa Therapeutics, Inc. | Freitag Gregory Gene | Director | Award | $6.5K |
| Jul 16 | ZVSA ZyVersa Therapeutics, Inc. | Cashmere Karen A. | Chief Commercial Officer | Award | $28.4K |
| Jul 15 | ZVSA ZyVersa Therapeutics, Inc. | Wolfe Peter | Chief Financial Officer | Award | $35.5K |
| Jul 15 | ZVSA ZyVersa Therapeutics, Inc. | Glover Stephen C. | Chief Executive Officer, Director | Award | $80.8K |
| Jul 15 | ZVSA ZyVersa Therapeutics, Inc. | Guzman Pablo A. | Chief Medical Officer | Award | $28.9K |
8 filings